Description: discussion of arbitrage possibilities cause by inconsistent mortality pricing assumptions in annuity products vis. a vis. life insurance products

Description: Discusses how companies must ensure that significant and necessary product development, and administrative and compliance system changes, have been completed and tested in time to accommodate new requirements.

Description: Mandatory implementation of life principle-based reserves (PBR) is just around the corner and there is no shortage of work to do, as most products have yet to be moved to PBR. Oliver Wyman recently completed its 2019 PBR survey, with more than 40 participants covering 85 percent of the individual life market, including 23 of the top 25 life writers and five reinsurers. This article will expand on the key survey findings, including implementation trends, analysis to date and recent discussions and decisions on the treatment of non-guaranteed reinsurance.

Description: Evaluation of the excess mortality element of the Group Conversion charge. Followed by several discussion papers submitted

Description: This paper describes a method of comparing net costs of dissimilar life insurance contracts. The principles are consistent with those of the interest-adjusted method recommended by the Moorhead committee. The significance of the results, possible applications of the method, and some concerns and conclusions are discussed.

Description: Results of survey conducted in July 2006 about the methods used by insurers to develop their pricing mortality assumptions for fully underwritten life insurance in the U.S. The objective was to understand how companies adjust base mortality tables and whether mortality improvement was assumed.

Description: This article discusses challenges in innovation, governance, and balancing the tension that naturally arises between them. Company culture is often a driver of success or failure in innovation. This article outlines a new dynamic to address this challenge.

Description: This 1979 session is about Life Company performance measures and pricing. Topics included: 1. What are appropriate performance criteria? a. In terms of financial results b. In terms of growth 2. How are goals established? a. For Mutual companies b. For Stock companies 3. What measurement tools do we use? a. Comparison of actual to expected results b. Compound growth rates c. Rules of thumb for various performance ratios d. Analysis of source of earnings 4. How are results used in pricing? a. Pricing consistent with goals are goals consistent with projections? b. Problems relating to allocation by line

Description: Presented at April 1985 Spring Meeting. Discusses new business developments which have led to a resurgence in term life sales and profitability.

Description: Presented at May 1985 Spring Meeting. This session discussed: Relationship of pricing and valuation actuaries in Canada, Financial reporting system as an information source for product development, Interaction of the pricing actuary, valuation actuary, and investment officer in designing interest-sensitive products, Allocation impact on product development of expense, investment income, tax, and capital, Financial reporting information in changing premium rates for nonguaranteed premium products, Maintaining consistency between pricing and financial projection models, Reserve basis and nonforfeiture basis impact on product development, with special reference to lapse-sensitive products.